Bone and Muscle Health Research Group, Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, 246 Clayton Road, Clayton, VIC, 3146, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), Melbourne Medical School, The University of Melbourne, St. Albans, Australia.
Arch Osteoporos. 2018 Sep 21;13(1):101. doi: 10.1007/s11657-018-0518-5.
The risk of mortality associated with high dietary calcium is uncertain. Unlike a highly publicised study in Swedish women, high dietary calcium intake in men-not women-was associated with increased all-cause mortality.
The association of dietary calcium with mortality is controversial. A study of women from the Swedish Mammography Cohort (SMC) suggested higher calcium was associated with higher mortality risk, whilst a study of Australian adults from the Melbourne Collaborative Cohort Study (MCCS) suggested higher intakes were associated with lower mortality risk. Thus, we aimed to perform a sex-specific re-analysis of the MCCS to evaluate the association of dietary calcium with mortality outcomes and directly compare hazard estimates (95% confidence intervals) in women with those from the SMC.
A prospective cohort study of community-dwelling Australian adults was conducted, in which 34,627 individuals (women 20,834 (60.2%); mean ± SD, age = 54 ± 8 years) were included at baseline after excluding those with prevalent cardiovascular (CV) disease, cancer or incomplete data. Energy-adjusted dietary calcium was categorised into the following levels of consumption (mg/day): < 600, 600-999, 1000-1399 and ≥ 1400. Mortality from all-causes, any cardiovascular disease and myocardial infarction was determined. Mortality hazards relative to intakes were estimated to be of 600-999 mg/day.
In women, hazard estimates for calcium intake of ≥ 1400 mg/day did not reach significance for all-cause (HR = 0.85; 0.66, 1.10) or CV (HR = 1.10; 0.69, 1.81) mortality in adjusted models. In men, intakes of ≥ 1400 mg/day were associated with a 42% increased all-cause mortality risk (HR = 1.42; 1.02, 1.99). There was a trend toward increased CV mortality (HR = 1.83; 0.94, 3.55).
Contrary to findings from a similar study conducted in Swedish women, Australian women, after adjustment for cofounders showed no increase in mortality risk with high calcium intakes possibly reflecting differences in calcium handling dynamics, diet or lifestyle factors between the two countries. We identified an increased risk for men.
高膳食钙与死亡率相关的风险尚不确定。与一项在瑞典女性中备受关注的研究不同,高膳食钙摄入与全因死亡率增加相关,而不是女性,而是男性。
膳食钙与死亡率的关系存在争议。一项来自瑞典乳腺队列研究(SMC)的女性研究表明,较高的钙与更高的死亡风险相关,而一项来自墨尔本协作队列研究(MCCS)的澳大利亚成年人研究表明,较高的摄入量与较低的死亡风险相关。因此,我们旨在对 MCCS 进行性别特异性重新分析,以评估膳食钙与死亡率结局的关系,并直接比较女性中的危险估计值(95%置信区间)与 SMC 中的危险估计值。
对社区居住的澳大利亚成年人进行了一项前瞻性队列研究,其中包括 34627 名参与者(女性 20834 人(60.2%);平均年龄±标准差为 54±8 岁),在排除了有心血管疾病(CV)、癌症或数据不完整的参与者后,纳入了基线。能量调整后的膳食钙分为以下消费水平(mg/天):<600、600-999、1000-1399 和≥1400。确定了所有原因、任何心血管疾病和心肌梗死的死亡率。与 600-999 mg/天的摄入量相比,死亡率的危险度估计值为 1400 mg/天以上。
在女性中,钙摄入量≥1400mg/天与全因(HR=0.85;0.66,1.10)或 CV(HR=1.10;0.69,1.81)死亡率的调整模型均无显著相关性。在男性中,摄入量≥1400mg/天与全因死亡率风险增加 42%相关(HR=1.42;1.02,1.99)。CV 死亡率呈上升趋势(HR=1.83;0.94,3.55)。
与在瑞典女性中进行的类似研究结果相反,澳大利亚女性在调整混杂因素后,高钙摄入与死亡率增加无关,这可能反映了两国之间钙处理动力学、饮食或生活方式因素的差异。我们发现男性风险增加。